Preferred Label : drug costs;

MeSH definition : The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES).;

MeSH synonym : costs, drug; cost, drug; drug cost;

DeCS synonym : Expenditures, Drugs;

MeSH annotation : costs to a health care facility or organiz: do not confuse with FEES, PHARMACEUTICAL or PRESCRIPTION FEES which are costs to the patient;

Details


Main resources

You can consult :

The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES).

https://www.cfp.ca/content/69/9/606
2023
Canada
journal article
Costs
Medication
Pharmacologic Substance
Vietnamese Language
Life
emergency medicine
Laser-Induced Fluorescence Endoscopy
drug costs
GDC Therapeutic Agent Terminology
cost of living
drug, nos
VIE Regimen
Emergency Medicine
Prescribing Domain
Comprehensive Score for Financial Toxicity

---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-manon-barchewitz
2023
France
audiovisual aids
blood group antigen en afs
blood group antigen u1a
blood group antigen rd a
blood group antigen a3
blood group antigen nijhuis
blood group antigen rh a
blood group antigen a x
blood group antigen di a
blood group antigen cr3
blood group antigen vg a
blood group antigen zt a
Economics
blood group antigen rb a
blood group antigen ch a
blood group antigen do a
blood group antigen wr a
blood group antigen es a
blood group antigen vr
blood group antigen tg a
blood group antigen sd a
Perception
blood group antigen c
blood group antigen a1 le b
blood group antigen a1b
blood group antigen at a
blood group antigen mi a
blood group antigen pr a
blood group antigen mo a
blood group antigen cl a
blood group antigen jk a
blood group antigen a.m.
commerce
Perception
blood group antigen wd a
perception
blood group antigen en akt
blood group antigen le c
blood group antigen m'
prices
blood group antigen a3b
blood group antigen rh42
blood group antigen a.m.
blood group antigen a2
blood group antigen le ns
blood group antigen fy a
blood group antigen le a
perception, nos
Patient Engagement
blood group antigen le x
blood group antigen pt a
blood group antigen ht a
cost savings
blood group antigen m1a
blood group antigen a2b
blood group antigen au a
blood group antigen wk a
blood group antigen ok a
blood group antigen 'n'
blood group antigen an a
blood group antigen jo a
blood group antigen yh a
blood group antigen jr a
patients
blood group antigen re a
blood group antigen tr a
awards and prizes
blood group antigen chr a
blood group antigen sk a
blood group antigen tj a
blood group antigen n a
blood group antigen dr a
economics
blood group antigen st a
blood group antigen rg a
blood group antigen sc2
blood group antigen hg a
drug costs
cost analysis
blood group antigen pr a
blood group antigen fr a
blood group antigen je a
blood group antigen kn a
blood group antigen le bl
blood group antigen bp a
blood group antigen dh a
blood group antigen to a
blood group antigen c
blood group antigen xg a
blood group antigen os a
has patient
antigen, nos
blood group antigen yt a
blood group antigen js a
blood group antigen ls a
patient participation
blood group antigen gy a
blood group antigen le d
blood group antigen le bh
blood group antigen mcc a
blood group antigen bg a
blood group antigen en afr
Economy
blood group antigen ny a
blood group antigen en ats
blood group antigen mt a
blood group antigen er a
blood group antigen go a
blood group antigen a1 le d
blood group antigen sw a
blood group antigen lu a
blood group antigen ol a
Antigens
blood group antigen or a
blood group antigen s1a
blood group antigen yk a
blood group antigen kp a
drug, nos
blood group antigen le b
blood group antigen co a
health
antigens
blood group antigen li a
blood group antigen bx a
blood group antigen in a
blood group antigen m a
blood group antigen lw a
blood group antigen r1a
blood group antigen ri a
blood group antigen jn a
blood group antigen sf a
blood group antigen be a
blood group antigen le s
blood group antigen lan
blood group antigen th a
blood group antigen lw b
blood group antigen jc a
blood group antigen cs a

---
https://papyrus.bib.umontreal.ca/xmlui/handle/1866/23567
2020
Canada
dissertations, academic
expenditures
health expenditures
drug costs
drug insurance
insurance, pharmaceutical services
drug, nos
Insurance

---
https://www.inspq.qc.ca/publications/2574
2019
false
false
false
Canada
comparative effectiveness research
10-valent pneumococcal vaccine
13-valent pneumococcal vaccine
Cost-Benefit analysis
pneumococcal infections
quebec
drug costs
economic evaluation
pneumococcal vaccines

---
https://www.cosprc.ca/fr/sustained-funding-to-ensure-access-to-anti-vascular-endothelial-growth-factor-drugs-2019/
2019
false
false
false
false
Canada
drug costs
wet macular degeneration
wet macular degeneration
Ranibizumab
Ranibizumab
aflibercept
aflibercept
Bevacizumab
Bevacizumab
macular edema
diabetic retinopathy
wet macular degeneration
insurance, health, reimbursement
canada
retinal diseases
guidelines
VEGF inhibitors
vascular endothelial growth factors
recombinant fusion proteins
receptors, vascular endothelial growth factor
recombinant fusion proteins
receptors, vascular endothelial growth factor

---
http://www.sciencedirect.com/science/article/pii/S000745511600093X
http://dx.doi.org/10.1016/j.bulcan.2016.02.010
2016
false
false
false
France
French
journal article
drug costs
antineoplastic agents
insurance, health, reimbursement
reimbursement mechanisms
insurance, health, reimbursement
legislation as topic
interdisciplinary communication
drug prescriptions
innovative therapies
Off-Label use
neoplasms
hospitals
therapies, investigational

---
http://www.irdes.fr/recherche/2016/questions-d-economie-de-la-sante.html#n220
http://www.irdes.fr/recherche/questions-d-economie-de-la-sante/220-strategies-de-desinvestissement-des-produits-pharmaceutiques.pdf
2016
false
false
false
France
French
review of literature
pharmaceutical preparations
australia
canada
france
United Kingdom
new zealand
Value-Based purchasing
drug costs
cost control
treatment outcome
insurance, health, reimbursement

---
https://www.has-sante.fr/portail/jcms/c_2580906/fr/evaluation-medico-economique-des-traitements-de-fond-biologiques-dans-la-prise-en-charge-de-la-polyarthrite-rhumatoide
2015
false
false
false
France
economic evaluation
technical report
Cost-Benefit analysis
drug costs
antibodies, monoclonal
antibodies, monoclonal
treatment outcome
tumor necrosis factor-alpha
methotrexate
Leflunomide
sulfasalazine
hydroxychloroquine
biosimilar pharmaceuticals
Etanercept
Adalimumab
Infliximab
Certolizumab Pegol
golimumab
Abatacept
Rituximab
tocilizumab
sarilumab
anakinra
practice guidelines as topic
biological therapy
arthritis, rheumatoid
interleukin 1 receptor antagonist protein
antibodies, monoclonal, humanized
Tumor Necrosis Factor Inhibitors

---
https://www.inspq.qc.ca/publications/2035
2015
false
false
false
false
Canada
French
technical report
disabled persons
quebec
drug costs
cost savings
obesity
obesity
invalidism
obesity, nos
consumption
drug, nos
economics
economics

---
http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/14vol40/dr-rm40s-2/index-fra.php
http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/14vol40/dr-rm40s-2/assets/pdf/14vol40s-2-fra.pdf
2014
false
false
false
Canada
French
drug resistance, microbial
journal article
anti-bacterial agents
drug costs
anti-bacterial agents
antibiotic therapy

---
http://www.avisdexperts.ch/videos/view/3182/1/a%3A1%3A%7Bs%3A3%3A%22Tag%22%3Ba%3A1%3A%7Bi%3A0%3Bs%3A8%3A%22MEDECINE%22%3B%7D%7D
2014
false
false
false
Switzerland
French
hepatitis C
drug costs
antiviral agents
antiviral agents
drug combinations
video recording
Sofosbuvir
Sofosbuvir

---
http://www.has-sante.fr/portail/jcms/c_1554860/fr/evaluation-par-classe-des-medicaments-antihypertenseurs
http://www.has-sante.fr/portail/jcms/c_1561303/fr/rapport-evaluation-par-classe-des-medicaments-antihypertenseurs
2013
true
France
French
antihypertensive agents
economic evaluation
drug evaluation
hypertension
sodium chloride symporter inhibitors
adrenergic beta-antagonists
angiotensin receptor antagonists
angiotensin-converting enzyme inhibitors
calcium channel blockers
treatment outcome
antihypertensive agents
economics, pharmaceutical
drug costs
cardiovascular diseases
primary prevention
antihypertensive agents
medication adherence

---
http://www.insee.fr/fr/themes/document.asp?ref_id=ip1408&reg_id=0
2012
false
true
false
France
drug costs
insurance, health
insurance, health, reimbursement
drug costs
scientific and technical information

---
https://iris.who.int/discover?query=Maitrise%20des%20couts%20des%20medicaments%20importes
Switzerland
French
health status
health expenditures
Health Workforce
financing, organized
drug industry
legislation, pharmacy
medication systems
drug prescriptions
drugs, generic
drug utilization
economics, pharmaceutical
commerce
costs and cost analysis
drug costs
tunisia
technical report

---
https://iris.who.int/discover?query=Sources%20et%20prix%20d%27une%20selection%20de%20medicaments%20et%20tests%20diagnostiques%20pour%20les%20personnes%20vivant%20avec%20le%20VIH/SIDA
Switzerland
French
technical report
drug costs
costs and cost analysis
drug evaluation
hiv infections
acquired immunodeficiency syndrome
developing countries
drugs, essential
economics, pharmaceutical
acquired immunodeficiency syndrome
hiv infections

---
https://iris.who.int/discover?query=Accords%20de%20l%27OMC%20et%20la%20sante%20publique%20(Les)
Switzerland
French
public health
economics
international agencies
world health organization
health policy
economics, medical
infection control
food inspection
smoking
drug costs
technical report

---
http://www.e-cancer.fr/content/download/63483/571173/file/ETUSITCHIM12.pdf
2012
true
France
French
scientific and technical information
economic evaluation
neoplasms
antineoplastic agents
drug therapy
drug therapy
antineoplastic agents
drug costs

---
http://www.pmprb-cepmb.gc.ca/
Canada
English
French
establishment, institution, organization
canada
drug costs

---
http://www.academie-medecine.fr/11-04-mise-au-point-sur-la-prescription-des-molecules-onereuses-en-cancerologie/
2011
false
false
France
French
drug prescriptions
antineoplastic agents
drug costs
technical report

---
http://www.obsan.admin.ch/fr/publications/consommation-et-cout-des-medicaments-en-suisse
http://www.obsan.admin.ch/sites/default/files/publications/2015/obsan_50_rapport.pdf
2011
false
true
false
false
Switzerland
pharmaceutical preparations
pharmaceutical preparations
drug costs
pharmaceutical preparations
antihypertensive agents
anticholesteremic agents
psychotropic drugs
antihypertensive agents
anticholesteremic agents
psychotropic drugs
technical report
switzerland
drug costs

---
http://kce.fgov.be/fr/node/724
2009
false
Belgium
French
Tiotropium Bromide
Tiotropium Bromide
lung diseases, obstructive
bronchodilator agents
drug costs
bronchodilator agents
tiotropium bromide
drug evaluation
health technology assessment
economic evaluation
french abstract
treatment outcome

---
http://www.cochrane.org/fr/CD005979
2009
false
true
false
United Kingdom
France
drug costs
review of literature
french abstract
costs and cost analysis

---
http://www.mediam.ext.cnamts.fr/get/index.htm
2005
France
French
drugs, generic
drug costs
costs and cost analysis
economics, pharmaceutical
handbooks

---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/034000374.pdf
2003
France
French
pharmaceutical preparations
france
legislation, pharmacy
health expenditures
drug industry
drug costs
health expenditures
economics, hospital
hospital costs
hospital administration
social security
drug approval
education, continuing
financing, organized
medication systems, hospital
costs and cost analysis
regional medical programs
community networks
pharmacy service, hospital
hospital information systems
hospitals, teaching
drug utilization
hospitals
information dissemination
drug utilization review
pharmacists
drug prescriptions
economics, pharmaceutical
pharmaceutical preparations
medical order entry systems
health policy guidelines
technical report

---
http://www.who.int/hiv/pub/prev_care/en/Improving%20accessF.pdf
2003
true
Switzerland
French
developing countries
health services accessibility
hiv infections
acquired immunodeficiency syndrome
hiv infections
acquired immunodeficiency syndrome
counseling
hiv infections
acquired immunodeficiency syndrome
mass screening
patient education as topic
patient rights
Self-Help groups
terminal care
pain measurement
terminally ill
child
infectious disease transmission, vertical
sex education
prenatal care
anti-hiv agents
risk factors
breast feeding
aids-related opportunistic infections
tuberculosis
hiv infections
acquired immunodeficiency syndrome
diet
complementary therapies
benin
biomedical research
pregnant women
pregnancy
health services
anti-hiv agents
algorithms
africa
drug costs
uganda
financing, organized
home care services
Health Workforce
health plan implementation
drugs, essential
hiv infections
acquired immunodeficiency syndrome
community networks
costs and cost analysis
thailand
brazil
drugs, generic
drug industry
hiv infections
acquired immunodeficiency syndrome
aids-related opportunistic infections
health services research
health policy guidelines
technical report

---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/bdc/e-docs/00/03/FC/CE/resume.md?type=text.html
2003
France
French
English
journal article
economic evaluation
antineoplastic agents
drug costs
neoplasms
costs and cost analysis
antineoplastic agents
antineoplastic agents
france
neoplasms
health expenditures
evaluation studies as topic
costs and cost analysis
health expenditures
economics, hospital
health expenditures
neoplasms

---
http://drees.social-sante.gouv.fr/IMG/pdf/serieetud23.pdf
2002
France
French
practice guidelines as topic
consensus development conferences as topic
guideline adherence
drug prescriptions
france
drug utilization
antacids
anti-ulcer agents
duodenal ulcer
stomach ulcer
anti-ulcer agents
antacids
anti-ulcer agents
economics, pharmaceutical
anti-ulcer agents
costs and cost analysis
drug costs
commerce
stomach ulcer
duodenal ulcer
antacids
antacids
antacids
anti-ulcer agents
journal article

---
http://www.has-sante.fr/portail/display.jsp?id=c_454163
http://www.has-sante.fr/portail/display.jsp?id=c_451925
2001
France
French
drug costs
economics, pharmaceutical
drug industry
drug evaluation
drug utilization review
evaluation studies

---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/964123700.pdf
1996
France
French
drug costs
hospital charges
technical report

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.